• 검색어에 아래의 연산자를 사용하시면 더 정확한 검색결과를 얻을 수 있습니다.
  • 검색연산자
검색연산자 기능 검색시 예
() 우선순위가 가장 높은 연산자 예1) (나노 (기계 | machine))
공백 두 개의 검색어(식)을 모두 포함하고 있는 문서 검색 예1) (나노 기계)
예2) 나노 장영실
| 두 개의 검색어(식) 중 하나 이상 포함하고 있는 문서 검색 예1) (줄기세포 | 면역)
예2) 줄기세포 | 장영실
! NOT 이후에 있는 검색어가 포함된 문서는 제외 예1) (황금 !백금)
예2) !image
* 검색어의 *란에 0개 이상의 임의의 문자가 포함된 문서 검색 예) semi*
"" 따옴표 내의 구문과 완전히 일치하는 문서만 검색 예) "Transform and Quantization"
쳇봇 이모티콘
ScienceON 챗봇입니다.
궁금한 것은 저에게 물어봐주세요.

논문 상세정보

골관절염환자에 있어서 경피투여후 피록시캄의 조직분포

Disposition of Piroxicam Following Transdermal Administration in Patients with Osteoarthritis


Background : Piroxicam(P) is usually administered once or twice a day for the treatment of arthritis. Since arthritis is a chronic disease, patients require a long term therapy with P, which results in a number of side effects such as gastrointestinal disorders and bleeding. In order to lessen these side effects and to increase patient's compliance, the P transdermal patch has been developed. The purpose of this study was to compare the disposition of transdermal P with that of oral P at steady state. Methods : A total of twenty patients (4 males and 16 females) aged 54 to 77 years with osteoarthritis were randomized and equally divided into 2 group. Group I was treated with $Trast^{TM}$ transdermal patch containing 48mg of P (manufactured by Sunkyong Pharm., Seoul) on the knee every other day for 14 days, and Group II received oral P 20mg once a day for 14 days. We collected plasma and tissue samples from Group I at 36 hrs after the last application of transdermal patch and from Group II at 12 hrs following the last oral dose. P Concentrations in plasma and tissues were analyzed by high-performance liquid chromatography(HPLC) with UV detection. Wilcoxon rank sum test was performed to evaluate the differences between the two formulations. Results : P concentration in plasma following transdermal administration was significantly lower compared to that of oral administration $(0.11{\pm}0.19\;vs.\;5.69{\pm}2.26{\mu}g/ml,\;p<0.01)$. However, there was no statistical difference in the synovial fluid between Group I and Group II $(5.44{\pm}0.36\;vs.\;5.37{\pm}3.72{\mu}g/ml,\;p=0.2483)$, while the inter-individual differences were lesser in Group I than in Group II (coefficient variation ; 6.6% vs. 69.3%). When compared to Group II, P concentrations In Group I were significantly lower in synovium, muscle, and adipose tissue $(0.0101{\pm}0.0148\;vs.\;0.0740{\pm}0.0249,0.0036{\pm}0.0021\;vs.\;0.0552{\pm}0.0341,and\;0.0034{\pm}0.0019\;vs.\;0.0256{\pm}0.0118{\mu}g/g;p<0.01)$ Conclusion : The plasma concentration in Group I was 50 times lower than that in Group II, but the synovial fluid concentration was comparable, suggesting that the transdermal patch would be expected to produce equivalent therapeutic effects and reduce systemic side effects.

저자의 다른 논문

참고문헌 (0)

  1. 이 논문의 참고문헌 없음

이 논문을 인용한 문헌 (0)

  1. 이 논문을 인용한 문헌 없음


원문 PDF 다운로드

  • 원문 PDF 정보가 존재하지 않습니다.

원문 URL 링크

  • 원문 URL 링크 정보가 존재하지 않습니다.

원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다. (원문복사서비스 안내 바로 가기)

상세조회 0건 원문조회 0건

DOI 인용 스타일